Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder

NCT00209807 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Major Depression
Pain
Abdominal Pain

Interventions

DRUG: escitalopram
DRUG: Reboxetine
OTHER: No intervention

Sponsor

Hospital Universitari Vall d'Hebron Research Institute